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infection, underlying disease(s), the
medical setting in which the infection
occurred, the appropriateness of
antibiotics prescribed, the age and sex
of the patients, no increased death was
associated with MRSA, although
inappropriate therapy was associated
with a poorer outcome. In contrast, for
bone infections and mediastinitis,
MRSAmay increase the risk of death. 
The complete results of standard
antimicrobial susceptibility tests are
not generally available to the pre-
scriber before at least 48–72 hours.
The initial regimen prescribed may be
not adequate during the first 2 to 3
days of treatment. This may impact
death or illness attributable to multi-
resistant bacteria. Shortening this
interval, rapid diagnosis techniques
based on molecular identification of
resistance mechanisms could improve
outcome. For example, methicillin
resistance in S. aureus colony is
detectable within 6 hours. Studies on
clinical specimens showed that resist-
ance-detection techniques, coupled
with DNA identification of the bac-
terium, gave an excellent concordance
to discriminate MRSAand MSSAand
for MDRTB. Advances in the field of
DNA microchips might soon improve
the clinical impact of these tech-
niques. 
With more clinical failures, more
expensive alternative regimens, the
cost-effectiveness ratio of the treat-
ment of antimicrobial bacterial resist-
ant infections will inevitably rise.
However, very few studies have
addressed this issue; it requires pre-
cise and documented scenarios based
on close collaboration between clini-
cians, microbiologists, epidemiolo-
gists and economists. Proposing
prospective scenarios and foreseeing
all the public health consequences of
antimicrobial bacterial resistance is
difficult. Although the impact on life
expectancy should remain relatively
limited in western nations, this will
not be the case in developing coun-
tries where alternative regimens are
usually either not available or too
costly. 
Quantifying the consequences of
antimicrobial bacterial resistance is a
key element for allocating resources
for public health programs. Some evi-
dence exists of such consequences on
illness and death, most of which
appear to be associated with inappro-
priate or delayed therapy. Never-
theless, more studies which take into
account the specific methodologic
difficulties mentioned above are need-
ed to better convince policy makers. 
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Vets, Meds, and
Zoonotic Threats
The fourth international confer-
ence on emerging zoonoses
(September 18–21, Ames, Iowa,
USA) brought together 180 scientists
and healthcare specialists from 18
countries working to control diseases
transmitted from animals to humans.
The meeting took place under the aus-
pices of the Center of Food Security
and Public Health, USA, and the
Institute for International Cooperation
in Animal Biologics (a collaborating
center of the World Animal Health
Organisation [OIE]).
A multidisciplinary and global
approach shed new light on both old
and new zoonoses. For example, bru-
cellosis topics covered a wide range
of material, from economic aspects of
control in Mongolia to characteriza-
tion of Brucella isolates from feral
swine in coastal South Carolina.
Another presentation concerned the
increasingly appreciated role of
wildlife in the dynamic epidemiology
of other zoonotic infections, such as
tuberculosis. Scientists also explored
the intricate routes prions follow
between wildlife and domestic ani-
mals; between sheep, cattle, and
humans; and between the tongue and
brain of infected animals. 
Since most agents of bioterrorism
potential are zoonotic, a full session
was dedicated to bioterrorism and
biodefense. It included a global view,
a report on national preparedness by
Israeli hospitals, and examples of
research that may eventually help
experts coping with bioterrorism but
would also unfortunately be accessi-
ble to persons with malicious intent.
Innovative methods for preventing
spread of foodborne pathogens were
presented, including the use of fluo-
rescence spectroscopy to detect fecal
contamination on animal carcasses or
the use of vaccination to reduce trans-
mission of zoonotic pathogens and
drug-resistant nonpathogens through
the food chain to humans. In the field
of xenotransplantation, key compo-
nents of a source-animal production
facility were described. The feasibili-
ty of breeding pigs free of designated
pathogens offers hope for wide use of
xenotransplantation in the near future. 
Participants also discussed current
trends and challenges of protozoan
parasitic zoonoses, including cryp-
tosporidiosis, toxoplasmosis, African
and Latin American trypanosomiasis,
and leishmaniasis. Controversial
zoonotic viruses were given an impor-
tant place in the conference. These
included hepatitis E virus, with simi-
lar strains causing liver disease in
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swine and humans; Borna disease
virus, causing neurologic disease in
various species of animals as well as,
debatably, psychiatric disorders in
humans; and the recently discovered
severe acute respiratory
syndrome–associated coronavirus and
its yet-undefined animal reservoir.
The recent mapping of the genome of
Mycobacterium avium subspecies
paratuberculosis, the etiologic agent
of Jhone’s disease in cows, brought
some hope in solving the long-lasting
dispute on its role in the pathogenesis
of Crohn’s disease in humans.
The value of using a global, multi-
disciplinary approach was highlighted
in studies on the flow of genes among
avian, swine, and other influenza
viruses and on the ongoing interconti-
nental spread of arboviruses, exempli-
fied by the evolving epizootic of
equine West Nile encephalitis in the
United States. Several papers dealt
with the epidemiology of Nipah,
Ebola, monkeypox, rabies, and
Hantaan viruses.
A series of presentations demon-
strated how genomic fingerprinting
and other sophisticated molecular
biology techniques allow exceptional-
ly fast development in understanding
the epidemiology and pathogenesis of
many zoonotic infections, such as
those caused by Escherichia coli
O157:H7 or by species of Anaplasma,
Bartonella, Borrelia, Campylobacter,
Coxiella,  Francisella,  Pasteurella,
and Salmonella. 
The “one-track” meeting, by
avoiding parallel and superspecialized
sessions, gave an opportunity for
fruitful and inspiring interactions
among experts from multiple disci-
plines with a shared goal of mitigating
human disease from emerging infec-
tions. More details on the meeting can
be viewed online (available at:
http://www.zoonoses2003.com).
Silvio Pitlik*
*Rabin Medical Center-Beilison Campus,
Petah Tikva, Israel
Address for correspondence: Silvio Pitlik, Head,
Department of Medicine C and Infectious
Diseases, Rabin Medical Center-Beilison
Campus, Petah Tikva, Israel 49100; fax: 972-3-
9221605; email: pitlik@post.tau.ac.il 
Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 10, No. 4, April 2004 761
Correction, Vol. 10, No. 3
On p. 519, in the table entitled “Characteristics
of enterotoxigenic Escherichia coli (ETEC) out-
breaks, United States, 1996–2003,” the serotype
of the strain associated with outbreak number 16
was O169:H41 not O169:H49.
Conference Presentations
Online and on CD-ROM
Webcasts–some enhanced by the visual presenta-
tions– of the International Conference on Women
and Infectious Diseases (February 27 - 28, 2004) and
the International Conference on Emerging Infectious
Diseases (February 29 - March 3, 2004) are now
available.
Online access to the presentations is available to
conference attendees. A username and password are
required, previously emailed to all registrants. The
online sessions are accessible for a limited time only.
Conference presentations are also available on
CD-ROM, which includes audio for selected sessions
and visual elements for all sessions. A CD-ROM may
be purchased for ICWID (US $99.00 plus shipping)
and for ICEID (US $129.00 plus shipping) from
Conference Archives. Call 1-866-316-3289 or 1-814-
536-3356 (outside the United States) to purchase.
Additional information is available at 
www.conferencearchives.com/icwid 
nd www.conferencearchives.com/iceid
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Policy on Corrections
The Emerging Infectious Diseases journal
wishes error-free articles. To that end, we  
1) Make corrections as quickly as we become
aware of errors
2) Publish corrections online and in print.
Online, we correct the error in the article it
occurred with a note that the article was corrected
and the date of correction. In print, we prominent-
ly publish a full correction, printing all needed
information, and provide the URL of the corrected
online article for reprints.
For additional information on corrections, send
e-mail to eideditor@cdc.gov.  